IBDEI10V ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16621,2)
;;=^5001356
;;^UTILITY(U,$J,358.3,16622,0)
;;=C78.01^^61^775^163
;;^UTILITY(U,$J,358.3,16622,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16622,1,3,0)
;;=3^Malig Neop Right Lung,Secondary
;;^UTILITY(U,$J,358.3,16622,1,4,0)
;;=4^C78.01
;;^UTILITY(U,$J,358.3,16622,2)
;;=^5001335
;;^UTILITY(U,$J,358.3,16623,0)
;;=C79.70^^61^775^114
;;^UTILITY(U,$J,358.3,16623,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16623,1,3,0)
;;=3^Malig Neop Adrenal Gland Unspec,Secondary
;;^UTILITY(U,$J,358.3,16623,1,4,0)
;;=4^C79.70
;;^UTILITY(U,$J,358.3,16623,2)
;;=^5001355
;;^UTILITY(U,$J,358.3,16624,0)
;;=C78.00^^61^775^147
;;^UTILITY(U,$J,358.3,16624,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16624,1,3,0)
;;=3^Malig Neop Lung Unspec,Secondary
;;^UTILITY(U,$J,358.3,16624,1,4,0)
;;=4^C78.00
;;^UTILITY(U,$J,358.3,16624,2)
;;=^5001334
;;^UTILITY(U,$J,358.3,16625,0)
;;=D57.1^^61^775^191
;;^UTILITY(U,$J,358.3,16625,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16625,1,3,0)
;;=3^Sickle-Cell Disease w/o Crisis
;;^UTILITY(U,$J,358.3,16625,1,4,0)
;;=4^D57.1
;;^UTILITY(U,$J,358.3,16625,2)
;;=^5002309
;;^UTILITY(U,$J,358.3,16626,0)
;;=D75.1^^61^775^189
;;^UTILITY(U,$J,358.3,16626,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16626,1,3,0)
;;=3^Polycythemia,Secondary
;;^UTILITY(U,$J,358.3,16626,1,4,0)
;;=4^D75.1
;;^UTILITY(U,$J,358.3,16626,2)
;;=^186856
;;^UTILITY(U,$J,358.3,16627,0)
;;=C90.30^^61^775^202
;;^UTILITY(U,$J,358.3,16627,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16627,1,3,0)
;;=3^Solitary Plasmacytoma,Not in Remission
;;^UTILITY(U,$J,358.3,16627,1,4,0)
;;=4^C90.30
;;^UTILITY(U,$J,358.3,16627,2)
;;=^5001759
;;^UTILITY(U,$J,358.3,16628,0)
;;=D56.3^^61^775^203
;;^UTILITY(U,$J,358.3,16628,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16628,1,3,0)
;;=3^Thalassemia Minor
;;^UTILITY(U,$J,358.3,16628,1,4,0)
;;=4^D56.3
;;^UTILITY(U,$J,358.3,16628,2)
;;=^340497
;;^UTILITY(U,$J,358.3,16629,0)
;;=D56.9^^61^775^204
;;^UTILITY(U,$J,358.3,16629,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16629,1,3,0)
;;=3^Thalassemia,Unspec
;;^UTILITY(U,$J,358.3,16629,1,4,0)
;;=4^D56.9
;;^UTILITY(U,$J,358.3,16629,2)
;;=^340606
;;^UTILITY(U,$J,358.3,16630,0)
;;=D51.2^^61^775^207
;;^UTILITY(U,$J,358.3,16630,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16630,1,3,0)
;;=3^Transcobalamin II Deficiency
;;^UTILITY(U,$J,358.3,16630,1,4,0)
;;=4^D51.2
;;^UTILITY(U,$J,358.3,16630,2)
;;=^5002286
;;^UTILITY(U,$J,358.3,16631,0)
;;=D05.92^^61^775^40
;;^UTILITY(U,$J,358.3,16631,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16631,1,3,0)
;;=3^Carcinoma in Situ Left Breast,Unspec Type
;;^UTILITY(U,$J,358.3,16631,1,4,0)
;;=4^D05.92
;;^UTILITY(U,$J,358.3,16631,2)
;;=^5001937
;;^UTILITY(U,$J,358.3,16632,0)
;;=D05.91^^61^775^42
;;^UTILITY(U,$J,358.3,16632,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16632,1,3,0)
;;=3^Carcinoma in Situ Right Breast,Unspec Type
;;^UTILITY(U,$J,358.3,16632,1,4,0)
;;=4^D05.91
;;^UTILITY(U,$J,358.3,16632,2)
;;=^5001936
;;^UTILITY(U,$J,358.3,16633,0)
;;=D05.90^^61^775^38
;;^UTILITY(U,$J,358.3,16633,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16633,1,3,0)
;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
;;^UTILITY(U,$J,358.3,16633,1,4,0)
;;=4^D05.90
;;^UTILITY(U,$J,358.3,16633,2)
;;=^5001935
;;^UTILITY(U,$J,358.3,16634,0)
;;=D51.0^^61^775^208
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10V 3774 printed Apr 09, 2024@21:30:38 Page 2
IBDEI10V ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16621,2)
+2 ;;=^5001356
+3 ;;^UTILITY(U,$J,358.3,16622,0)
+4 ;;=C78.01^^61^775^163
+5 ;;^UTILITY(U,$J,358.3,16622,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,16622,1,3,0)
+8 ;;=3^Malig Neop Right Lung,Secondary
+9 ;;^UTILITY(U,$J,358.3,16622,1,4,0)
+10 ;;=4^C78.01
+11 ;;^UTILITY(U,$J,358.3,16622,2)
+12 ;;=^5001335
+13 ;;^UTILITY(U,$J,358.3,16623,0)
+14 ;;=C79.70^^61^775^114
+15 ;;^UTILITY(U,$J,358.3,16623,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,16623,1,3,0)
+18 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
+19 ;;^UTILITY(U,$J,358.3,16623,1,4,0)
+20 ;;=4^C79.70
+21 ;;^UTILITY(U,$J,358.3,16623,2)
+22 ;;=^5001355
+23 ;;^UTILITY(U,$J,358.3,16624,0)
+24 ;;=C78.00^^61^775^147
+25 ;;^UTILITY(U,$J,358.3,16624,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,16624,1,3,0)
+28 ;;=3^Malig Neop Lung Unspec,Secondary
+29 ;;^UTILITY(U,$J,358.3,16624,1,4,0)
+30 ;;=4^C78.00
+31 ;;^UTILITY(U,$J,358.3,16624,2)
+32 ;;=^5001334
+33 ;;^UTILITY(U,$J,358.3,16625,0)
+34 ;;=D57.1^^61^775^191
+35 ;;^UTILITY(U,$J,358.3,16625,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,16625,1,3,0)
+38 ;;=3^Sickle-Cell Disease w/o Crisis
+39 ;;^UTILITY(U,$J,358.3,16625,1,4,0)
+40 ;;=4^D57.1
+41 ;;^UTILITY(U,$J,358.3,16625,2)
+42 ;;=^5002309
+43 ;;^UTILITY(U,$J,358.3,16626,0)
+44 ;;=D75.1^^61^775^189
+45 ;;^UTILITY(U,$J,358.3,16626,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,16626,1,3,0)
+48 ;;=3^Polycythemia,Secondary
+49 ;;^UTILITY(U,$J,358.3,16626,1,4,0)
+50 ;;=4^D75.1
+51 ;;^UTILITY(U,$J,358.3,16626,2)
+52 ;;=^186856
+53 ;;^UTILITY(U,$J,358.3,16627,0)
+54 ;;=C90.30^^61^775^202
+55 ;;^UTILITY(U,$J,358.3,16627,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,16627,1,3,0)
+58 ;;=3^Solitary Plasmacytoma,Not in Remission
+59 ;;^UTILITY(U,$J,358.3,16627,1,4,0)
+60 ;;=4^C90.30
+61 ;;^UTILITY(U,$J,358.3,16627,2)
+62 ;;=^5001759
+63 ;;^UTILITY(U,$J,358.3,16628,0)
+64 ;;=D56.3^^61^775^203
+65 ;;^UTILITY(U,$J,358.3,16628,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,16628,1,3,0)
+68 ;;=3^Thalassemia Minor
+69 ;;^UTILITY(U,$J,358.3,16628,1,4,0)
+70 ;;=4^D56.3
+71 ;;^UTILITY(U,$J,358.3,16628,2)
+72 ;;=^340497
+73 ;;^UTILITY(U,$J,358.3,16629,0)
+74 ;;=D56.9^^61^775^204
+75 ;;^UTILITY(U,$J,358.3,16629,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,16629,1,3,0)
+78 ;;=3^Thalassemia,Unspec
+79 ;;^UTILITY(U,$J,358.3,16629,1,4,0)
+80 ;;=4^D56.9
+81 ;;^UTILITY(U,$J,358.3,16629,2)
+82 ;;=^340606
+83 ;;^UTILITY(U,$J,358.3,16630,0)
+84 ;;=D51.2^^61^775^207
+85 ;;^UTILITY(U,$J,358.3,16630,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,16630,1,3,0)
+88 ;;=3^Transcobalamin II Deficiency
+89 ;;^UTILITY(U,$J,358.3,16630,1,4,0)
+90 ;;=4^D51.2
+91 ;;^UTILITY(U,$J,358.3,16630,2)
+92 ;;=^5002286
+93 ;;^UTILITY(U,$J,358.3,16631,0)
+94 ;;=D05.92^^61^775^40
+95 ;;^UTILITY(U,$J,358.3,16631,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,16631,1,3,0)
+98 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
+99 ;;^UTILITY(U,$J,358.3,16631,1,4,0)
+100 ;;=4^D05.92
+101 ;;^UTILITY(U,$J,358.3,16631,2)
+102 ;;=^5001937
+103 ;;^UTILITY(U,$J,358.3,16632,0)
+104 ;;=D05.91^^61^775^42
+105 ;;^UTILITY(U,$J,358.3,16632,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,16632,1,3,0)
+108 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
+109 ;;^UTILITY(U,$J,358.3,16632,1,4,0)
+110 ;;=4^D05.91
+111 ;;^UTILITY(U,$J,358.3,16632,2)
+112 ;;=^5001936
+113 ;;^UTILITY(U,$J,358.3,16633,0)
+114 ;;=D05.90^^61^775^38
+115 ;;^UTILITY(U,$J,358.3,16633,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,16633,1,3,0)
+118 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
+119 ;;^UTILITY(U,$J,358.3,16633,1,4,0)
+120 ;;=4^D05.90
+121 ;;^UTILITY(U,$J,358.3,16633,2)
+122 ;;=^5001935
+123 ;;^UTILITY(U,$J,358.3,16634,0)
+124 ;;=D51.0^^61^775^208
